New gene therapy restores dystrophin protein in patients with Duchenne muscular dystrophy

By | May 3, 2021
UT Southwestern scientists successfully employed a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD), uniquely utilizing CRISPR-Cas9-based tools to restore a large section of the dystrophin protein that is missing in many DMD patients.